Largest profit: XGX Pharma ApS (2016) '272 DKK
Most equity: Frederiksstaden Pharma ApS (2016) '9,678 DKK
Biggest loss: Frederiksstaden Pharma ApS (2013) '-1,901 DKK
Active
Director (2017-12-01 - present)
Ultimate beneficial owner (2017-11-01 - 2025-07-21) 38% ownership (2024-06-01 – 2025-07-21 ) 39.5% ownership (2022-01-28 – 2022-07-06 ) 43% ownership (2022-07-07 – 2024-05-31 ) 43.12% ownership (2019-11-22 – 2022-01-27 ) 50% ownership (2017-11-01 – 2019-11-21 ) 38% voting rights (2024-06-01 – 2025-07-21 ) 39.5% voting rights (2022-01-28 – 2022-07-06 ) 43% voting rights (2022-07-07 – 2024-05-31 ) 43.12% voting rights (2019-11-22 – 2022-01-27 ) 50% voting rights (2017-11-01 – 2019-11-21 )
Board member (2018-11-01 - 2025-07-21)
Legal owner (2017-11-01 - 2017-12-21) 50% ownership (2017-11-01 – 2017-12-21 ) 50% voting rights (2017-11-01 – 2017-12-21 )
Active
Ultimate beneficial owner (2019-12-02 - present) 25.83% ownership (2021-05-01 – 2022-01-27 ) 27.17% ownership (2019-12-27 – 2021-04-30 ) 39.5% ownership (2022-01-28 – ) 43.12% ownership (2019-12-02 – 2019-12-26 ) 25.83% voting rights (2021-05-01 – 2022-01-27 ) 27.17% voting rights (2019-12-27 – 2021-04-30 ) 39.5% voting rights (2022-01-28 – ) 43.12% voting rights (2019-12-02 – 2019-12-26 )
Board member (2019-12-19 - 2022-05-05)
Director (2019-12-02 - 2020-02-01)
Board member (2019-12-02 - 2019-12-18)
Active
Ultimate beneficial owner (2025-03-11 - present) 50% ownership (2025-03-11 – ) 50% voting rights (2025-03-11 – )